Sector: Pharmaceutical PreparationsIndustry: BiotechnologyCountry: USExchange: Nasdaq
DilutionScan read 35 of BioAge Labs, Inc.'s SEC filings and found 3 warrant series, 2 convertibles, 1 ATM program, 3 shelf registrations and 4 completed offerings on file for BIOA. The latest dilution event on file is ATM sales on Jun 30, 2026. Analysis updated Oct 31, 2026.
DilutionScan ProEvery instrument in full ยท $59/mo
Covered companies in Biotechnology. All tickers A to Z
IPSCCentury Therapeutics, Inc.
LYELLyell Immunopharma, Inc.
LRMRLarimar Therapeutics, Inc.
QTTBQ32 Bio Inc.
FULCFulcrum Therapeutics, Inc.
NWBONorthwest Biotherapeutics, Inc.
LCTXLineage Cell Therapeutics, Inc.
LXEOLexeo Therapeutics, Inc. Common Stock
OCGNOcugen, Inc.
NAUTNautilus Biotechnolgy, Inc.
CAMPCAMP4 Therapeutics Corporation
FATEFate Therapeutics, Inc.
ABEOAbeona Therapeutics Inc.
CABACabaletta Bio, Inc.
IFRXInflaRx N.V. Common Stock